Overall rank by patents
#2,087
Across all tracked assignees
USPTO PatentsView assignee record - 189 granted patents across 19 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).
The verdict
Allscripts holds 189 US patents across 19 technology areas, rank #2,087 of 50,000 tracked assignees.
Allscripts Software, Llc has been granted 189 US utility patents between 2015 and 2025, placing Allscripts Software, Llc at rank #2,087 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.2 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, Allscripts Software, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Allscripts sits between Rigel Pharmaceuticals, Inc. (190 patents, rank #2,083) and Polycom, Llc (189 patents, rank #2,091) - the closest US assignees by grant volume. The composite Innovation Score of 46.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 110 grants, compared with 79 in the 2015–2019 window, a +39% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Allscripts Software, Llc's 17.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Allscripts Software, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Rigel Pharmaceuticals, Inc.
190 patents
SHIONOGI & CO., LTD.
190 patents
SMITH & NEPHEW ORTHOPAEDICS AG
190 patents
VOLVO LASTVAGNAR AB
190 patents
Chiesi Farmaceutici S.p.A.
189 patents
GN AUDIO A/S
189 patents
OKUMA CORPORATION
189 patents
Polycom, LLC
189 patents
Allscripts Software, LLC
189 patents
What this shows Allscripts holds 189 patents at rank #2,087, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,087 in granted patent volume.
Other assignees with the most granted patents in Allscripts's primary technology class.
Allscripts's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 21% higher than 79% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 2.6% |
| 2016 | 6 | 3.2% |
| 2017 | 14 | 7.4% |
| 2018 | 21 | 11.1% |
| 2019 | 33 | 17.5% |
| 2020 | 39 | 20.6% |
| 2021 | 32 | 16.9% |
| 2022 | 16 | 8.5% |
| 2023 | 12 | 6.3% |
| 2024 | 10 | 5.3% |
| 2025 | 1 | 0.5% |
Top 15 of 19 technology areas
Overall rank by patents
#2,087
Across all tracked assignees
46.3 out of 100
How to use this portfolio
Allscripts's 189 grants land it in the top 21% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.